Effect of dose and field strength on enhancement with paramagnetic contrast media.
暂无分享,去创建一个
V. Haughton | R. Prost | F. Yetkin | R. Lindsey | R. Lindsey
[1] V. Haughton,et al. Enhancement of intervertebral disks with gadolinium complexes: comparison of an ionic and a nonionic medium in an animal model. , 1994, AJNR. American journal of neuroradiology.
[2] M. C. Han,et al. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T. , 1994, AJNR. American journal of neuroradiology.
[3] A. Elster. Field-Strength Dependence of Gadolinium Enhancement: Theory and Implications , 1994 .
[4] T. Hilbertz,et al. Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength. , 1992, AJNR. American journal of neuroradiology.
[5] W G Bradley,et al. Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. , 1991, Radiology.
[6] J. Ehrhardt,et al. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. , 1991, Radiology.
[7] M. Modic,et al. Gd-DTPA enhancement of posterior epidural scar: an experimental model. , 1989, AJNR. American journal of neuroradiology.
[8] V. Haughton,et al. Cranial tissues: normal MR appearance after intravenous injection of Gd-DTPA. , 1986, Radiology.
[9] J. Peterson,et al. Comparison of full- and half-dose gadolinium-DTPA: MR imaging of the normal sella. , 1993, AJNR. American journal of neuroradiology.